EDC for dermatology clinical trials: skin and dermatologic endpoints, ePRO, and 21 CFR Part 11–aligned controls.
21 CFR Part 11 aligned · HIPAA-aligned security · No credit card required
Dermatology studies often depend on repeated clinician assessments that must be collected the same way at every visit. Depending on the condition and protocol, teams may need to capture lesion counts, affected body surface area, severity grades, investigator global assessments, treatment area location, flare status, rescue therapy use, or other structured skin findings. If those endpoints are entered as free text or split across paper worksheets, the data becomes harder to monitor, query, and analyze. Capture lets study teams build CRFs around the actual dermatology assessment plan. A visit form can guide the coordinator or investigator through the required scales, body regions, scoring fields, and protocol-specific comments. Required fields, branching logic, and consistent labels help reduce ambiguity between baseline and follow-up visits. When an assessment changes through a protocol amendment, the updated form can be managed with audit history rather than being handled through informal worksheets. This structure is useful for both clinical operations and analysis. Monitors can quickly identify missing assessments, out-of-window visits, inconsistent scores, or unusual changes from baseline. Analysts receive structured data that maps to the protocol endpoints instead of spending time cleaning narrative notes. For lean dermatology teams, that can make the difference between a dataset that is merely collected and one that is ready for review.
Skin conditions can affect participants in ways that are not fully captured by clinician scoring. Itch, pain, sleep disruption, embarrassment, treatment burden, and quality-of-life impact may fluctuate between visits. Dermatology studies often need scheduled questionnaires or symptom diaries so the participant perspective is captured alongside investigator assessments. Capture includes ePRO so those patient-reported measures can be managed in the same platform as the EDC. Teams can configure scheduled questionnaires, symptom diaries, and quality-of-life instruments with structured question types and skip logic. Site teams and monitors can review completion status without reconciling a separate survey vendor, and patient-reported data exports with the same participant identifiers used for CRFs. This is especially helpful when a study needs to compare visible clinical improvement with the participant's lived experience. A reduction in lesion severity may not fully explain sleep quality, itch intensity, or treatment satisfaction. Keeping these measures together gives the sponsor and investigators a clearer view of whether the intervention is changing outcomes that matter to participants, not only scores recorded during clinic visits.
Dermatology trials often involve visual documentation, protocol-defined assessment timing, and subjective scoring. Even when images are stored or reviewed in a separate workflow, the clinical dataset still needs to document what was assessed, when the assessment occurred, who performed it, what score was recorded, and how any related query was resolved. That traceability is important for sponsor review, publication, and regulated study support. Capture provides the governed EDC layer for that record. Teams can document image identifiers or assessment references, record investigator scores, capture deviations from required timing, and track queries against the participant visit. Role-based access helps separate site entry, investigator review, monitor review, and sponsor oversight. Audit trails preserve changes to clinical data and show how records evolved before database lock. For dermatology teams that do not need a large enterprise platform, this gives a practical operating model: use specialized image or assessment tools when the protocol requires them, but keep the clinical endpoint record, consent, ePRO, safety, and exports in one controlled study system. The result is easier review and less manual reconciliation at the end of the trial.
Overview
Dermatology clinical trials evaluate treatments for skin conditions with clinician-assessed and often patient-reported endpoints. Your EDC must support consent, CRFs, ePRO for symptom and QoL instruments, and full auditability for regulatory and publication use. Capture provides EDC, eConsent, ePRO, and safety in one platform with 21 CFR Part 11–aligned controls and HIPAA-aligned infrastructure, so dermatology study teams can capture clinical and PRO data with one audit trail.
Dermatology studies often use validated scales, photo documentation, and patient-reported outcomes. You need one system that handles consent, CRFs, and ePRO with the same audit trail and access controls. Standalone ePRO systems often don’t integrate with EDC. Capture integrates ePRO with EDC and eConsent so dermatology endpoints are captured with the same controls and audit history as clinical data.
FAQ
Explore the platform with a free sandbox. No sales call required.
Explore platform